You are viewing: Canada Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The Canada Biopreservation Market was valued at $72.9 Million in 2024 and projected to reach to $110 Million by 2029, representing a compound annual growth rate of 8.6%. Canada's biopreservation market is poised for sustained growth through 2029, driven by increasing adoption of advanced preservation technologies in research institutions, hospitals, and biotechnology companies.

Canada Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Biopreservation Market Trends and Insights

  • This expansion reflects Canada's advancing healthcare infrastructure and increasing adoption of cell and tissue preservation technologies across research institutions and clinical facilities.
  • Canada's biopreservation sector is driven by rising demand for regenerative medicine, biobanking applications, and the preservation of biological samples for therapeutic and research purposes. The Canadian market benefits from strong regulatory frameworks, government support for life sciences innovation, and collaboration between academic institutions and private sector players.
  • Canada's position as a leader in biotechnology research has accelerated investment in biopreservation infrastructure.
  • Between 2024 and 2029, Canada is expected to see enhanced adoption of cryopreservation and controlled-rate freezing technologies, supported by growing clinical applications in stem cell therapy and organ transplantation programs across Canadian healthcare systems..

Key Market Statistics

  • CAGR (2024-2029) 8.6% CAGR
  • Market Size, 2024 ~USD 72.9 Million
  • Forecast, 2029 ~USD 110 Million
  • Country Canada

Canada Biopreservation Market Overview

Market Valuation :

Canada's biopreservation market is valued at $72.9 million in 2024, with strong growth trajectory positioning it as a key regional market in North America's healthcare preservation sector.

Robust Growth Rate :

The Canadian market is expanding at a CAGR of 8.6% through 2029, outpacing many developed economies and reflecting increased investment in advanced preservation technologies and infrastructure.

Healthcare Infrastructure Advancement :

Canada's well-established healthcare system and research institutions are increasingly adopting cell and tissue preservation technologies, driving demand across clinical and research applications.

Regulatory Support :

Canada's progressive regulatory environment and alignment with international biopreservation standards are facilitating market expansion and attracting both domestic and international biotech investments.

Canada Biopreservation Market Dynamics

  • The country's strong healthcare infrastructure, coupled with rising investments in regenerative medicine and cell therapy research, creates favorable conditions for market expansion.
  • Canadian pharmaceutical and biotech firms are increasingly integrating biopreservation solutions into their operations, supporting the projected growth to $110 million by 2029. The market outlook is further strengthened by Canada's participation in global clinical trials and its commitment to precision medicine initiatives.
  • Government funding for life sciences research and private sector investments in biotech innovation are expected to accelerate adoption of cryopreservation and other preservation technologies.
  • Strategic partnerships between Canadian research institutions and international biotech companies will continue to drive market development and technological advancement..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Canada's biopreservation market is valued at $72.9 million in 2024 and is forecast to grow to $110.0 million by 2029, representing an 8.6% CAGR.
    • Canada's strong biotechnology research ecosystem and government support are key drivers of biopreservation technology adoption.
    • Regenerative medicine and biobanking applications are primary growth catalysts in Canada's biopreservation sector.
    • Canada's regulatory environment and academic-industry partnerships position the country as a competitive hub for biopreservation innovation.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    Canada Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    CANADA: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS57.466268.8575.8782.1790.8899.34108.999.6
    GENE BANKS28313336394347519.1
    HOSPITALS23262830333538428.4
    OTHER END USERS14161718202123258
    TOTAL122.46135146.85159.87174.17189.88207.34226.999.1

    Target Audience

    • Biotech & Pharmaceutical Companies : Canadian and international biotech firms need market-specific data to evaluate expansion opportunities, assess competitive positioning, and identify acquisition or partnership targets in Canada's growing biopreservation sector.
    • Healthcare Institutions & Research Centers : Canadian hospitals, research institutions, and academic medical centers require market insights to justify biopreservation technology investments, benchmark adoption rates, and plan infrastructure upgrades.
    • Medical Device & Equipment Manufacturers : Suppliers of cryopreservation equipment and biopreservation solutions need Canada-specific demand forecasts and market sizing to guide product development, pricing strategies, and sales planning.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Canada's life sciences sector require detailed market analysis, growth projections, and competitive landscape data to assess investment viability and portfolio positioning.
    • Government & Policy Makers : Canadian health authorities and policy organizations need market intelligence to inform healthcare innovation strategies, funding allocations, and regulatory frameworks supporting biopreservation advancement.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation of Canada's biopreservation market ($72.9M in 2024) with detailed CAGR analysis (8.6%) and 5-year forecasts to support investment decisions and business planning.
    • Regional Competitive Intelligence : Understand Canada-specific market dynamics, competitive landscape, and key players operating in the biopreservation sector to identify partnership and expansion opportunities.
    • Healthcare Infrastructure Insights : Gain detailed analysis of Canada's advancing healthcare infrastructure adoption of preservation technologies, including institutional demand drivers and clinical facility requirements.
    • Regulatory & Policy Framework : Comprehensive overview of Canada's biopreservation regulatory environment, compliance requirements, and government support mechanisms affecting market entry and growth strategies.
    • Strategic Market Positioning : Leverage Canada-specific market intelligence to develop targeted go-to-market strategies, identify high-growth segments, and optimize resource allocation for Canadian market penetration.

    Frequently asked questions

    What is the current size of Canada's biopreservation market?

    Canada's biopreservation market was valued at $72.9 million in 2024 and is expected to reach $110.0 million by 2029.

    What is the projected growth rate for Canada's biopreservation market?

    Canada's biopreservation market is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2029.

    What are the main drivers of growth in Canada's biopreservation market?

    Key drivers include increasing demand for regenerative medicine, expansion of biobanking infrastructure, clinical applications in stem cell therapy, and government support for life sciences innovation in Canada.

    Which applications are leading Canada's biopreservation market growth?

    Regenerative medicine, biobanking, stem cell preservation, and organ transplantation programs are the primary applications driving Canada's biopreservation market expansion.

    How does Canada's biopreservation market compare to global trends?

    Canada's 8.6% CAGR is slightly below the global average of 9.8%, reflecting a mature but steady market with strong institutional adoption and regulatory support.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status